Asymmetric dimethylarginine concentration and recurrence of atrial tachyarrythmias after catheter ablation in patients with persistent atrial fibrillation

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of interventional cardiac electrophysiology

• Publication date

  2011-05-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10840-011-9588-7PMID 21594627
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up?

  2011cited by this paper
• Changes in cytokine concentrations following successful ablation of atrial fibrillation.

  2010cited by this paper
• Effect of selected drugs on plasma asymmetric dimethylarginine (ADMA) levels.

  2010cited by this paper
• New insights into mechanisms of atrial fibrillation.

  2010cited by this paper
• Prevention of atrial fibrillation by Renin-Angiotensin system inhibition a meta-analysis.

  2010cited by this paper
• Role of inflammation and oxidative stress in atrial fibrillation.

  2010cited by this paper
• Interleukin-18 among atrial fibrillation patients in the absence of structural heart disease.

  2010cited by this paper
• A pre-existent elevated C-reactive protein is associated with the recurrence of atrial tachyarrhythmias after catheter ablation in patients with atrial fibrillation.

  2010cited by this paper
• Reactive oxidative metabolites are associated with atrial conduction disturbance in patients with atrial fibrillation.

  2009cited by this paper
• Reduced testosterone levels in males with lone atrial fibrillation

  2009cited by this paper
• Asymmetric dimethylarginine (ADMA): an endogenous inhibitor of nitric oxide synthase and a novel cardiovascular risk molecule.

  2009cited by this paper
• Reversal of Atrial Remodeling after Cardioversion of Persistent Atrial Fibrillation Measured with Magnetocardiography

  2009cited by this paper
• Effects of Rosuvastatin on Asymmetric Dimethylarginine Levels and Early Atrial Fibrillation Recurrence after Electrical Cardioversion

  2009cited by this paper
• Current concepts in the pathogenesis of atrial fibrillation.

  2009cited by this paper
• Asymmetric Dimethylarginine Concentration and Early Recurrence of Atrial Fibrillation after Electrical Cardioversion

  2008cited by this paper
• Oxidative Stress and Inflammation in Atrial Fibrillation: Role in Pathogenesis and Potential as a Therapeutic Target

  2008cited by this paper
• Variance of DDAH/PRMT/ADMA pathway in atrial fibrillation dogs.

  2008cited by this paper
• Asymmetrical dimethylarginine level in atrial fibrillation

  2008cited by this paper
• Inflammation and atrial fibrillation: cause or effect?

  2008cited by this paper
• The role of the renin-angiotensin system in atrial fibrillation and the therapeutic effects of ACE-Is and ARBS.

  2008cited by this paper
• [Asymmetric dimethyl arginine (ADMA): a novel cardiovascular risk factor?].

  2007cited by this paper
• Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation.

  2007cited by this paper
• HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation.

  2007cited by this paper
• The role of the post-cardioversion time course of hs-CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation

  2007cited by this paper
• Asymmetrisches Dimethyl Arginin (ADMA): Ein neuer kardiovaskulärer Risikofaktor?

  2007cited by this paper
• Endothelial cell function during atrial fibrillation and after restoration of sinus rhythm.

  2007cited by this paper
• Plasma brain natriuretic peptide level after radiofrequency catheter ablation of paroxysmal, persistent, and permanent atrial fibrillation.

  2007cited by this paper
• Plasma natriuretic peptide concentrations as a predictor for successful catheter ablation in patients with drug-refractory atrial fibrillation.

  2007cited by this paper
• Is atrial fibrillation an inflammatory disorder?

  2006cited by this paper
• Asymmetric dimethylarginine (ADMA) a novel cardiovascular risk factor--evidence from epidemiological and prospective clinical trials.

  2006cited by this paper
• Is atrial fibrillation an inflammatory disorder?

  2006cited by this paper
• Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation.

  2005cited by this paper
• Inflammation in the genesis and perpetuation of atrial fibrillation.

  2005cited by this paper
• Asymmetrical Dimethylarginine: The Über Marker?

  2004cited by this paper
• Asymmetric Dimethylarginine Produces Vascular Lesions in Endothelial Nitric Oxide Synthase–Deficient Mice: Involvement of Renin-Angiotensin System and Oxidative Stress

  2004cited by this paper
• Catheter Ablation of Paroxysmal Atrial Fibrillation Initiated by Non–Pulmonary Vein Ectopy

  2003cited by this paper
• Electrophysiological remodeling in human atrial fibrillation.

  2003cited by this paper
• Development of Heart Failure and Congenital Septal Defects in Mice Lacking Endothelial Nitric Oxide Synthase

  2002cited by this paper
• Electrical, contractile and structural remodeling during atrial fibrillation.

  2002cited by this paper
• Biatrial multisite mapping of atrial premature complexes triggering onset of atrial fibrillation.

  2002cited by this paper
• Pathophysiology and Prevention of Atrial Fibrillation

  2001cited by this paper
• Ablation of right and left atrial premature beats following cardioversion in patients with chronic atrial fibrillation refractory to antiarrhythmic drugs.

  2000cited by this paper
• Histological substrate of atrial biopsies in patients with lone atrial fibrillation.

  1997cited by this paper
• Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells.

  1996cited by this paper
• Simulation study of confounder-selection strategies.

  1993cited by this paper
• Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure.

  1992cited by this paper
• Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter.

  1991cited by this paper
• Nitric oxide: an endogenous modulator of leukocyte adhesion.

  1991cited by this paper

• Risk factors for the recurrence of atrial fibrillation after catheter ablation: a meta-analysis

  2025cites this paper
• Unveiling the Role of Endothelial Dysfunction: A Possible Key to Enhancing Catheter Ablation Success in Atrial Fibrillation

  2024cites this paper
• Endothelial function and atrial fibrillation: A missing piece of the puzzle?

  2021cites this paper
• Left atrial structure and function predictors of recurrent fibrillation after catheter ablation: a systematic review and meta‐analysis

  2020cites this paper
• Effect of fish oil on circulating asymmetric dimethylarginine and adiponectin in overweight or obese patients with atrial fibrillation

  2020cites this paper
• Endothelial damage and thromboembolic risk after pulmonary vein isolation using the latest ablation technologies: a comparison of the second-generation cryoballoon vs. contact force-sensing radiofrequency ablation

  2018cites this paper
• The characterisation of risk factors, substrate and management strategies for atrial fibrillation.

  2015cites this paper
• Nitric Oxide Bioavailability in Obstructive Sleep Apnea: Interplay of Asymmetric Dimethylarginine and Free Radicals

  2015cites this paper
• Atrial Fibrillation Is Associated with a Marker of Endothelial Function and Oxidative Stress in Patients with Acute Myocardial Infarction

  2015cites this paper
• New insights into symptomatic or silent atrial fibrillation complicating acute myocardial infarction.

  2015cites this paper
• La fibrillation atriale, silencieuse ou symptomatique, compliquant un infarctus du myocarde : déterminants, impact pronostique et rôle des dérivés méthylés de la L-arginine et du stress oxydatif

  2015cites this paper
• Increased levels of inflammatory and extracellular matrix turnover biomarkers persist despite reverse atrial structural remodeling during the first year after atrial fibrillation ablation

  2014influential citation
• Plasma Asymmetric Dimethylarginine and Adverse Events in Patients with Atrial Fibrillation Referred for Coronary Angiogram

  2013cites this paper